Screening for MECP2 mutations in females with autistic disorder

A. E. Ashley-Koch, R. J. Carney, C. M. Wolpert, Michael Cuccaro, John Gilbert, Jeffery M Vance, Margaret A Pericak-Vance

Research output: Contribution to journalArticle

Abstract

Autistic Disorder (AD) and Rett Disorder (RD) are both Pervasive Developmental Disorders. Recently, it was discovered that mutations in the MECP2 gene cause RD. Because of the phenotypic similarity between RD and AD, we screened 69 females in families ascertained for AD. A clinical diagnosis of AD in each patient was confirmed using the ADI-R. Patients with RD features, such as microcephaly, had been excluded from this dataset. Patients were screened for MECP2 variants using DHPLC followed by sequencing. Mutations in the MECP2 gene were identified in two females. Patient one (age 10 years) developed normally until age 30 months when she regressed in language and motor skills. Head circumference is at the 25th percentile. She did not lose purposeful hand movements and never developed RD stereotyped hand movements. She has a 1047C > T nonsense mutation resulting in an R293X aa change and premature protein truncation. Patient two (age 16 years) developed normally until 18 months when problems in response to social and language stimuli were noted. Head circumference is at the 50th percentile. She never developed RD stereotyped hand movements. She is heterozygous for a 41 bp deletion at 1324-1364del, resulting in a frameshift and protein truncation. Mutations in both patients are de novo. These results suggest all females presenting with AD should be screened for MECP2 mutations.

Original languageEnglish
JournalAmerican Journal of Medical Genetics - Neuropsychiatric Genetics
Volume105
Issue number7
StatePublished - Oct 8 2001
Externally publishedYes

Fingerprint

Rett Syndrome
Autistic Disorder
Mutation
Hand
Language
Head
Microcephaly
Motor Skills
Nonsense Codon
Genes
Proteins

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)

Cite this

Screening for MECP2 mutations in females with autistic disorder. / Ashley-Koch, A. E.; Carney, R. J.; Wolpert, C. M.; Cuccaro, Michael; Gilbert, John; Vance, Jeffery M; Pericak-Vance, Margaret A.

In: American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 105, No. 7, 08.10.2001.

Research output: Contribution to journalArticle

@article{6cd49e23ac9843f9b2f97d62e61dc0c0,
title = "Screening for MECP2 mutations in females with autistic disorder",
abstract = "Autistic Disorder (AD) and Rett Disorder (RD) are both Pervasive Developmental Disorders. Recently, it was discovered that mutations in the MECP2 gene cause RD. Because of the phenotypic similarity between RD and AD, we screened 69 females in families ascertained for AD. A clinical diagnosis of AD in each patient was confirmed using the ADI-R. Patients with RD features, such as microcephaly, had been excluded from this dataset. Patients were screened for MECP2 variants using DHPLC followed by sequencing. Mutations in the MECP2 gene were identified in two females. Patient one (age 10 years) developed normally until age 30 months when she regressed in language and motor skills. Head circumference is at the 25th percentile. She did not lose purposeful hand movements and never developed RD stereotyped hand movements. She has a 1047C > T nonsense mutation resulting in an R293X aa change and premature protein truncation. Patient two (age 16 years) developed normally until 18 months when problems in response to social and language stimuli were noted. Head circumference is at the 50th percentile. She never developed RD stereotyped hand movements. She is heterozygous for a 41 bp deletion at 1324-1364del, resulting in a frameshift and protein truncation. Mutations in both patients are de novo. These results suggest all females presenting with AD should be screened for MECP2 mutations.",
author = "Ashley-Koch, {A. E.} and Carney, {R. J.} and Wolpert, {C. M.} and Michael Cuccaro and John Gilbert and Vance, {Jeffery M} and Pericak-Vance, {Margaret A}",
year = "2001",
month = "10",
day = "8",
language = "English",
volume = "105",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Screening for MECP2 mutations in females with autistic disorder

AU - Ashley-Koch, A. E.

AU - Carney, R. J.

AU - Wolpert, C. M.

AU - Cuccaro, Michael

AU - Gilbert, John

AU - Vance, Jeffery M

AU - Pericak-Vance, Margaret A

PY - 2001/10/8

Y1 - 2001/10/8

N2 - Autistic Disorder (AD) and Rett Disorder (RD) are both Pervasive Developmental Disorders. Recently, it was discovered that mutations in the MECP2 gene cause RD. Because of the phenotypic similarity between RD and AD, we screened 69 females in families ascertained for AD. A clinical diagnosis of AD in each patient was confirmed using the ADI-R. Patients with RD features, such as microcephaly, had been excluded from this dataset. Patients were screened for MECP2 variants using DHPLC followed by sequencing. Mutations in the MECP2 gene were identified in two females. Patient one (age 10 years) developed normally until age 30 months when she regressed in language and motor skills. Head circumference is at the 25th percentile. She did not lose purposeful hand movements and never developed RD stereotyped hand movements. She has a 1047C > T nonsense mutation resulting in an R293X aa change and premature protein truncation. Patient two (age 16 years) developed normally until 18 months when problems in response to social and language stimuli were noted. Head circumference is at the 50th percentile. She never developed RD stereotyped hand movements. She is heterozygous for a 41 bp deletion at 1324-1364del, resulting in a frameshift and protein truncation. Mutations in both patients are de novo. These results suggest all females presenting with AD should be screened for MECP2 mutations.

AB - Autistic Disorder (AD) and Rett Disorder (RD) are both Pervasive Developmental Disorders. Recently, it was discovered that mutations in the MECP2 gene cause RD. Because of the phenotypic similarity between RD and AD, we screened 69 females in families ascertained for AD. A clinical diagnosis of AD in each patient was confirmed using the ADI-R. Patients with RD features, such as microcephaly, had been excluded from this dataset. Patients were screened for MECP2 variants using DHPLC followed by sequencing. Mutations in the MECP2 gene were identified in two females. Patient one (age 10 years) developed normally until age 30 months when she regressed in language and motor skills. Head circumference is at the 25th percentile. She did not lose purposeful hand movements and never developed RD stereotyped hand movements. She has a 1047C > T nonsense mutation resulting in an R293X aa change and premature protein truncation. Patient two (age 16 years) developed normally until 18 months when problems in response to social and language stimuli were noted. Head circumference is at the 50th percentile. She never developed RD stereotyped hand movements. She is heterozygous for a 41 bp deletion at 1324-1364del, resulting in a frameshift and protein truncation. Mutations in both patients are de novo. These results suggest all females presenting with AD should be screened for MECP2 mutations.

UR - http://www.scopus.com/inward/record.url?scp=33749092571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749092571&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749092571

VL - 105

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 7

ER -